Safety and Effectiveness of Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation and Anemia: A Retrospective Cohort Study

BACKGROUND: Major randomized trials assessing non–vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation generally excluded patients with hemoglobin <10 g/dL. This study evaluated the safety and effectiveness of NOACs in patients with atrial fibrillation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chun‐Li, Wu, Victor Chien‐Chia, Huang, Yu‐Tung, Kuo, Chang‐Fu, Chu, Pao‐Hsien, Chen, Yu‐Ling, Wen, Ming‐Shien, Chang, Shang‐Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512084/
https://www.ncbi.nlm.nih.gov/pubmed/31020896
http://dx.doi.org/10.1161/JAHA.119.012029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6512084/
https://www.ncbi.nlm.nih.gov/pubmed/31020896
http://dx.doi.org/10.1161/JAHA.119.012029

Ejemplares similares